Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Azenta (AZTA)

Azenta completes $63 million sale of B Medical Systems to Thelema

Neutral Impact 4 of 5 m&a Written later

Azenta said it completed the sale of B Medical Systems to Thelema S.à r.l. on July 1, 2026, for a fixed $63 million, of which $28 million was paid in cash and $35 million was funded by a secured vendor loan to Thelema. The filing states that Thelema is majority owned by Luc Provost, a Vice President of Azenta and CEO of B Medical, and that the Audit Committee approved the arrangements as a related-party transaction. The pro forma balance sheet shows a $41.5 million reduction to retained earnings tied to cumulative translation adjustments and estimated cost to sell.

Key points

  • Purchase price: $63 million fixed, with no customary post-closing adjustments; $28 million cash and a $35 million vendor loan
  • Vendor loan to Thelema: $35 million at 6.0% interest, maturing three months after funding, secured by a first-priority pledge over B Medical equity
  • Related-party transaction: Thelema is majority owned by Luc Provost, a Vice President of Azenta and CEO of B Medical; Audit Committee approved
  • The transaction had not closed by March 31, 2026, due to Thelema's inability to secure financing at that time

The filing

CompanyAzenta (AZTA)
Form8-K, current report
Filed with the SECJul 8, 2026, 8:03 AM ET
Accession number0001628280-26-047591

Items reported: 1.01 Material Definitive Agreement2.01 Acquisition or Disposition Completed7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:54 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.